February 11, 2016 /
TNF-α
blocking drugs, such as infliximab, surprised investigators when their use in
people with multiple sclerosis (MS) actually triggered demyelination. In a
case report published in the journal Neuroimmunology &
Neuroinflammation, Vanderbilt University Medical Center researchers
reviewed an aggressive demyelinating event in a non-MS patient treated
with TNF-α blockers. TNF-α blockers are used to slow the progression
of autoimmune diseases with an […]
blocking drugs, such as infliximab, surprised investigators when their use in
people with multiple sclerosis (MS) actually triggered demyelination. In a
case report published in the journal Neuroimmunology &
Neuroinflammation, Vanderbilt University Medical Center researchers
reviewed an aggressive demyelinating event in a non-MS patient treated
with TNF-α blockers. TNF-α blockers are used to slow the progression
of autoimmune diseases with an […]
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
MS Views and News
helps to provide educational information for persons affected by MS
Keep current with Multiple Sclerosis news and information
by opting-in to our website: click here – thank you
.===================================
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
Stay informed with MS news and information - Sign-up here
For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY CHAT
